Published in Chest on February 24, 2011
Bronchial Infection in Patients With COPD and Frequent Exacerbations. | NCT03259022
Respiratory Microbiome in COPD and Associated Inmune Response. | NCT03321708
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.06
Local burn injury impairs epithelial permeability and antimicrobial peptide barrier function in distal unburned skin. Crit Care Med (2014) 1.47
Barrier function of airway tract epithelium. Tissue Barriers (2013) 1.02
DAMPs activating innate and adaptive immune responses in COPD. Mucosal Immunol (2013) 0.89
Coal fly ash impairs airway antimicrobial peptides and increases bacterial growth. PLoS One (2013) 0.86
Pulmonary biomarkers in COPD exacerbations: a systematic review. Respir Res (2013) 0.83
Targeting pro-resolution pathways to combat chronic inflammation in COPD. J Thorac Dis (2014) 0.81
Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-α and chemokine production by human lung parenchyma. PLoS One (2013) 0.79
A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort. PLoS One (2014) 0.77
Antimicrobial peptide LL-37 circulating levels in chronic obstructive pulmonary disease patients with high risk of frequent exacerbations. J Thorac Dis (2015) 0.76
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1. BMC Pulm Med (2015) 0.75
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med (2002) 7.87
Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med (2008) 4.33
Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med (2009) 4.27
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A (1998) 3.83
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest (2003) 3.19
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med (2000) 3.00
Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J (1999) 2.96
Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 2.96
Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J (2004) 2.70
Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med (2005) 2.61
Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest (1991) 2.54
The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol (2003) 2.50
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J (1999) 2.44
Epithelial antimicrobial peptides in host defense against infection. Respir Res (2000) 2.40
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med (1995) 2.08
The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci U S A (2009) 2.07
Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol (1999) 1.93
Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.93
Cathelicidins--a family of multifunctional antimicrobial peptides. Cell Mol Life Sci (2003) 1.89
Alveolar macrophages as orchestrators of COPD. COPD (2004) 1.79
Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med (1990) 1.67
Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis (2004) 1.63
Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J (2000) 1.50
Lysozyme secretion by submucosal glands protects the airway from bacterial infection. Am J Respir Cell Mol Biol (2005) 1.49
Antimicrobial polypeptides. J Leukoc Biol (2003) 1.46
Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med (1999) 1.45
Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation. Chest (2005) 1.44
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.38
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer (2007) 1.36
Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer (2005) 1.35
Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest (1991) 1.31
Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor. J Biol Chem (2001) 1.30
The role of the multifunctional peptide LL-37 in host defense. Front Biosci (2008) 1.23
Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int Arch Allergy Immunol (2006) 1.20
Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells. Infect Immun (2009) 1.16
Secretion of lactoferrin and lysozyme by cultures of human airway epithelium. Am J Physiol Lung Cell Mol Physiol (2004) 1.10
Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. Breast Cancer Res (2009) 1.10
In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase. Infect Immun (1985) 1.10
Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol (1993) 1.01
Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochem Soc Trans (2006) 0.91
Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease. BMC Infect Dis (2009) 0.89
The antimicrobial peptide LL-37 enhances IL-8 release by human airway smooth muscle cells. J Allergy Clin Immunol (2006) 0.88
A possible role for lysozyme in determining acute exacerbation in chronic bronchitis. Clin Exp Immunol (1995) 0.88
Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex. Respir Res (2008) 0.81
Iron-binding proteins in sputum of chronic bronchitis patients with Haemophilus influenzae infections. Eur Respir J (1997) 0.79